Boston Scientific Logo

SPOTLIGHT
DISCOVER INNOVATION3


COGNIS™ and TELIGEN ™ is an innovative technology platform, the fruit of years of research at Boston Scientific, offering you a COMPLETE range of features, VERSATILE programming options and a USER-FRIENDLY interface for optimal treatment and maximum safety of your patients. Ready for LATITUDE™ Remote Patient Management*, COGNIS™ and TELIGEN™ offer the opportunity for convenient home-based patient monitoring and follow-up.
*LATITUDE™ Remote Patient Management System is not yet CE marked and not yet available in the EEA
.....................................................................................................................................................................................................................

Smaller Size with High Energy

  • Only 9.9 mm thin for all COGNIS™ and TELIGEN™ devices
  • Available with IS-1 and 4-SITE 1

Reliability on a High Safety Margin 1-3

  • All devices with 41 J stored energy with fast and stable charge time

Longevity with Stable Charge Time

Benefice from improved device management

  • Increased and predictable longevity
  • Extended warranty

Increase the Treatment Efficacy

  • Stable charge time throughout entire life of device

Simplified Sensing

Optimization of arrhythmia detection

  • Completely redesigned sensing circuitry featuring newly developed Dynamic Noise Algorithm (D.N.A)
  • Simple and intuitive programmable sensitivity (in mV)

Minimization of false-positive events

  • New sensing filter 4 designed to significantly reduce myopotential and noise oversensing
  • Less unnecessary mode switching

Enhanced Rhythm ID™ and OBDE

Choice between 2 sets of algorithms to achieve the best discrimination tailored to the patient:

  • Enhanced Rhythm ID: Programmable AFib rate and stability to customize each type of arrhythmia
  • One Button Detection Enhancement (OBDE): Onset and stability discriminators

Reduction of inappropriate shocks

  • Highest specificity and sensitivity 5, 6 for confidence for appropriate treatment

Expanded Electronic Repositioning (COGNIS™) 7-9

Electronic Repositioning™

Getting the best electrical parameters and avoid diaphragmatic stimulation

  • Six programmable LV pacing configurations
  • Non-invasive solution for post-op diaphragmatic stimulation

Using Electronic Repositioning ™ even with unipolar LV leads

  • Two new programmable unipolar LV pacing configurations

New and Comprehensible User Interface

The programmer speaks the clinical language

  • Indication Based Programming (I.B.P.), with 4 comprehensive clinical questions suggesting the appropriate programming
  • Uncomplicated programming of device features

More efficiency with highly convenient and fast follow-ups

  • Simple summary screens displaying exactly
  • Intelligent cross-checking minimizes the probability of parameter interactions

The programmer offers the whole range of programming options

  • Quick and convenient access
  • Progressive levels of disclosure

References:
1. Russo AM et al., Defibrillation Threshold Testing: Is it Really Necessary at the Time of Implantable Cardioverter-Defibrillator Insertion? Heart Rhythm 2005; 2(5):456-461
2. Gold MR et al., Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation (LESS Study). Circulation 2002; 105(17):2043-2048
3. Swerdlow CD et al., The Dilemma of ICD Implant Testing. PACE 2007; 30(5):675-700
4. ACUTE Clinical Study
5. Dorian P et al., A randomized clinical trial of standardized protocol for the prevention of inappropriate therapy using a dual chamber implantable cardioverter defibrillator. Presented at the 72nd Scientific Sessions of the American Heart Association, November 1999. Abstract 4152
6. Gold MR et al., Advanced Rhythm Discrimination for Implantable Cardioverter Defibrillators Using Electrogram Vector Timing and Correlation. J Cardiovasc Electrophysiol. 2002; 13(11):1092-1097
7. Gurevitz O et al., Programmable Multiple Pacing Configurations Help to Overcome High Left Ventricular Pacing Thresholds and Avoid Phrenic Nerve Stimulation. PACE 2005; 28(12):1255-1259
8. Electronic Repositioning with a Bipolar Coronary Venous Lead [AHA 2004 abstract] (C3-254)
9. Utility of Electronic Reprogrammable Vectors in Biventricular Devices [ACC 2006 abstract] (C3-255)